The potential secretary for Health and Human Services has been forced to defend his previous anti-vaccine stances at his ...
Kashiv Biosciences has reported that a trial of its 125mg/mL pre-filled syringe injection, KSHB002, has achieved its primary ...
Ryght AI has partnered with Cancer Research South Australia (CRSA) to advance cancer clinical trials and expand patient ...
Degrees Pharmaceuticals has received approval from the IRB for a Phase II trial of Arakoda (tafenoquine) for treating chronic babesiosis.